Cargando…
Hyperhomocysteinemia and Lupus Nephritis
Background In SLE, both disease-specific and traditional risk factors are important. Increased serum homocysteine levels are seen in approximately 15% of patients with systemic lupus erythematosus and are associated with an increased risk of atherothrombotic events in this population. The serum lev...
Autores principales: | Timlin, Homa, Manno, Rebecca, Douglas, Homeyra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721921/ https://www.ncbi.nlm.nih.gov/pubmed/31516776 http://dx.doi.org/10.7759/cureus.5065 |
Ejemplares similares
-
Pericarditis in Lupus
por: Dein, Eric, et al.
Publicado: (2019) -
Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension
por: Machireddy, Kirthi, et al.
Publicado: (2018) -
Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage
por: Dein, Eric, et al.
Publicado: (2018) -
Treatment Using Both Voclosporin and Belimumab in Four Patients With Lupus Nephritis
por: Baum, Rebecca, et al.
Publicado: (2023) -
Anakinra for Recurrent Fevers in Systemic Lupus Erythematosus
por: Dein, Eric, et al.
Publicado: (2018)